Login / Signup

Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease.

Wan-Yu ChuMaaike NijmanRaymond StegemanJohannes M P J BreurNicolaas J G JansenJoppe NijmanKim van LoonErik KoomenKarel AllegaertManon J N L BendersThomas P C DorloAlwin D R Huitemanull null
Published in: Clinical pharmacokinetics (2024)
. The decreased CL of both compounds during CPB suggests influence of the hypothermia, hemofiltration, and the potential sequestration of allopurinol in the circuit. The reduced CL of oxypurinol after CPB is likely attributable to impaired kidney function.
Keyphrases
  • congenital heart disease
  • cardiac arrest
  • brain injury
  • low birth weight
  • human health
  • preterm infants
  • risk assessment